Stock Earnings
H.C. Wainwright’s latest rating for ADAP stock
Adaptimmune Therapeutics Plc ADR’s recent filing unveils that its Chief Financial Officer Wood Gavin unloaded Company’s shares for reported $950.0
Menu
Adaptimmune Therapeutics Plc ADR’s recent filing unveils that its Chief Financial Officer Wood Gavin unloaded Company’s shares for reported $950.0
In a filing, Adaptimmune Therapeutics Plc ADR revealed its Chief Financial Officer Wood Gavin unloaded Company’s shares for reported $950.0
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Adaptimmune Therapeutics Plc ADR’s recent filing unveils that its Chief Financial Officer Wood Gavin unloaded Company’s shares for reported $950.0
Adaptimmune Therapeutics Plc ADR’s recent filing unveils that its Chief Financial Officer Wood Gavin unloaded Company’s shares for reported $950.0
In a filing, Adaptimmune Therapeutics Plc ADR revealed its Chief Financial Officer Wood Gavin unloaded Company’s shares for reported $950.0
In a filing, Adaptimmune Therapeutics Plc ADR revealed its Chief Operating Officer Bertrand William C JR unloaded Company’s shares for
Adaptimmune Therapeutics Plc ADR’s filing revealed that its Director Behbahani Ali unloaded Company’s shares for reported $0.18 million on Aug
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Adaptimmune Therapeutics Plc ADR revealed its Affiliate New Enterprise Associates, 14 acquired Company’s shares for reported $0.98